Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis

Clinical trial NCT03265613 · COMPLETED

Trial details

NCT number: NCT03265613
Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mesenchymal Stromal Cells Psoriasis Drug Toxicity Drug Effect

Start date: 2017-09-24
Primary completion: 2019-08-20
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.